CDX2 |
Ainv15 (embryonic stem cells) |
+RA +Hh +Dox +FGF |
Permissive
Robust
|
Mus musculus |
GSE39433
...
|
MA0465.2
|
CDX2 |
Ainv15 (embryonic stem cells) |
+RA +Hh +Dox |
Permissive
Robust
|
Mus musculus |
GSE39433
...
|
MA0465.2
|
CDX2 |
Ainv15 (embryonic stem cells) |
+Dox +FGF |
Permissive
Robust
|
Mus musculus |
GSE39435
...
|
MA0465.2
|
CDX2 |
Ainv15 (embryonic stem cells) |
+Dox +FGF |
Permissive
Robust
|
Mus musculus |
GSE39435
...
|
MA0465.2
|
CDX2 |
motor neuron progenitors |
none |
Permissive
|
Mus musculus |
GSE39435
...
|
MA0465.2
|
CDX2 |
epiblast stem cells |
24h CHIR99021 + Fgf8 |
Permissive
Robust
|
Mus musculus |
GSE84899
...
|
MA0465.2
|
CDX2 |
jejunal epithelial cells |
Treatment: injected with 1mg Tamoxifen for 5 consecutive days Genotype: Cdx2 f/f (cdx2 knockout) Villin-cre Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine |
Permissive
|
Mus musculus |
GSE98724
...
|
MA0465.2
|
CDX2 |
jejunal epithelial cells |
Treatment: sunflower oil (vehicle for tamoxifen) Genotype: wildtype (Cdx2 f/f (cdx2 knockout)) Strain: B6, 129 mixed background Source: Mouse intestinal villus epithelial cells Cell type: Adult differentiated jejunal epithelial cell, middle 1/3 of intestine |
Permissive
Robust
|
Mus musculus |
GSE98724
...
|
MA0465.2
|
CDX2 |
embryonic whole tissue from midgut |
Strain: C57BL6; Developmental stage: E16.5; Genotype: Wild-Type(Cdx2 f/f; vil-Cre-ERT2 X Cdx2 f/f; vil-Cre-ERT2); |
Permissive
Robust
|
Mus musculus |
GSE115314
...
|
MA0465.2
|
CDX2 |
embryonic whole tissue from midgut |
Strain: CD1; Developmental stage: E17.5; |
Permissive
Robust
|
Mus musculus |
GSE115314
...
|
MA0465.2
|
CDX2 |
villus epithelium |
Strain: mixed; Developmental stage: adult; |
Permissive
Robust
|
Mus musculus |
GSE115314
...
|
MA0465.2
|
CDX2 |
duodenal cells |
Treatment: none; Genotype: wildtype; Donor: patient 1; |
Permissive
|
Homo sapiens |
GSE115314
...
|
MA0465.2
|
CDX2 |
duodenal cells |
Treatment: none; Genotype: wildtype; Donor: patient 2; |
Permissive
|
Homo sapiens |
GSE115314
...
|
MA0465.2
|
CDX2 |
Wnt+Fgf-specified intestinal culture cells |
Genotype: wildtype; |
Permissive
Robust
|
Homo sapiens |
GSE115314
...
|
MA0465.2
|
CDX2 |
naive endoderm |
Treatment: Doxycycline; Genotype: wildtype; Source: induced CDX2 culture cells; |
Permissive
Robust
|
Homo sapiens |
GSE115314
...
|
MA0465.2
|
CDX2 |
NIH 3T3 (embryonic fibroblasts) |
Genotype: Overexpression of CDX2; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding; |
Permissive
Robust
|
Mus musculus |
GSE119782
...
|
MA0465.2
|
CDX2 |
embryo |
Genotype: wildtype; Developmental stage: E8.5; Strain: Mixed; Source: whole embryo; |
Permissive
|
Mus musculus |
GSE128858
...
|
MA0465.2
|
CDX2 |
intestinal villus |
|
Permissive
Robust
|
Mus musculus |
GSE24633
...
|
MA0465.2
|
CDX2 |
villus |
|
Permissive
|
Mus musculus |
GSE34566
...
|
MA0465.2
|
CDX2 |
villus |
|
Permissive
Robust
|
Mus musculus |
GSE34566
...
|
MA0465.2
|
CDX2 |
ZHBTc4-TS (trophoblast stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE51511
...
|
MA0465.2
|
CDX2 |
endodermal cells |
|
Permissive
Robust
|
Mus musculus |
GSE39435
...
|
MA0465.2
|
CDX2 |
intestinal stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE70766
...
|
MA0465.2
|
CDX2 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0465.2
|
CDX2 |
LS174T (colon adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE97273
...
|
MA0465.2
|
CDX2 |
COLO-320 (colon adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE30026
|
MA0465.2
|
CDX2 |
Caco-2 (colon adenocarcinoma) |
DIFF |
Permissive
|
Homo sapiens |
GSE23436
|
MA0465.2
|
CDX2 |
Caco-2 (colon adenocarcinoma) |
PROLIF |
Permissive
Robust
|
Homo sapiens |
GSE23436
|
MA0465.2
|
CDX2 |
LS180 (colon cancer) |
125 |
Permissive
Robust
|
Homo sapiens |
GSE31939
|
MA0465.2
|
CDX2 |
LS180 (colon cancer) |
|
Permissive
Robust
|
Homo sapiens |
GSE31939
|
MA0465.2
|